Goran Mitulović: Proteomics and Mass Spectroscopy Identified The Cause of VITT
Goran Mitulović, Senior Application Development Scientist (Field based) at Bruker Daltonics, shared on LinkedIn about a recent article by Jing Jing Wang et al, published in NEJM:
”Do you remember CoVID, the vaccines, and the particular issues with the Astrazeneca and Jonson and Jonson vaccines?
Well, groundbreaking research was just published, and proteomics and mass spectroscopy helped identify the cause of VITT (vaccine-induced immune thrombocytopenia and thrombosis).”
Title: Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Authors: Jing Jing Wang, Linda Schönborn, Theodore E. Warkentin, Luisa Müller, Thomas Thiele, Lena Ulm, Uwe Völker, Sabine Ameling, Sören Franzenburg, Lars Kaderali, Ana Tzvetkova, Alex Colella, Tim Chataway, Chee Wee Tan, Bridie Armour, Alexander Troelnikov, Lucy Rutten, James McCluskey, Roland Zahn
Read the Full Article on NEJM
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 2, 2026, 16:30Sam K. Saha: The Hardest Cases Are the Ones You Can’t Save
-
Apr 2, 2026, 16:20Veronica Sanchez: Know Stroke Signs and Act Fast
-
Apr 2, 2026, 16:08Ney Carter Borges: Early Surgery vs Conservative Care in Asymptomatic Very Severe Aortic Stenosis
-
Apr 2, 2026, 15:52Gevorg Yaghjyan: How Yale is Redefining Bladder Cancer Treatment Through Strategy Focused Trials
-
Apr 2, 2026, 15:10Webinar on the Role of Omega-3 Fatty Acids in Cardiovascular Health – EAS
-
Apr 2, 2026, 15:06Leonardo Roever: Atherofrailty Score Offers a A Novel Machine Learning Approach to Stroke Risk Stratification
-
Apr 2, 2026, 14:55André da Silva: Stroke Is Not an Explosion – It’s Often a Silent Loss of Blood Flow
-
Apr 2, 2026, 14:39Maria Τektonidou: STAT1 as a Potential Therapeutic Target in Thrombotic Antiphospholipid Syndrome
-
Apr 2, 2026, 14:18Deise Catamo Vaz: WSO Future Stroke Leaders Project Offers A Closing for Large Information Gap in PSCI